My favourite piece, the last sentence. 7 days of trading left.
In brief.
Canntab Therapeutics was founded on April 20, 2016 by pharmaceutical industry professionals who saw an urgent need to add industry rigour and professionalism to the medicinal cannabis market. We are the first company solely dedicated to the research and development of oral dosage therapeutic formulations of cannabis. We started by developing unique, patent pending technology which has resulted in the creation of a range of oral dosage products that effectively treat different ailments by delivering a uniform dosage of medicinal cannabis extract. Each is available in different dosage levels, available in instant and stable extended release.
Simply put, Canntab is a game changer in the medicinal cannabis market.
CGB Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
